Effects of dronedarone, amiodarone and their active metabolites on sequential metabolism of arachidonic acid to epoxyeicosatrienoic and dihydroxyeicosatrienoic acids-Reference-Cited by-同舟云学术

Effects of dronedarone, amiodarone and their active metabolites on sequential metabolism of arachidonic acid to epoxyeicosatrienoic and dihydroxyeicosatrienoic acids

Published:2017-12 Issue: Volume:146 Page:188-198
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Karkhanis Aneesh,Tram Nhan Dai Thien,Chan Eric Chun Yong

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference60 articles.

1. Eicosanomics: Targeted lipidomics of eicosanoids in biological systems;Balazy;Prostaglandins Other Lipid Mediat.,2004

2. Cytochrome P450 enzymes: central players in cardiovascular health and disease;Elbekai;Pharmacol. Ther.,2006

3. P-450 metabolites of arachidonic acid in the control of cardiovascular function;Roman;Physiol. Rev.,2002

4. Mechanisms by which epoxyeicosatrienoic acids (EETs) elicit cardioprotection in rat hearts;Gross;J. Mol. Cell. Cardiol.,2007

5. Epoxides and soluble epoxide hydrolase in cardiovascular physiology;Imig;Physiol. Rev.,2012

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CYP2J2-mediated metabolism of arachidonic acid in heart: A review of its kinetics, inhibition and role in heart rhythm control;Pharmacology & Therapeutics;2024-06

2. Sorafenib reduces the production of epoxyeicosatrienoic acids and leads to cardiac injury by inhibiting CYP2J in rats;Biochemical Pharmacology;2024-05

3. Investigating the association between CYP2J2 inhibitors and QT prolongation: a literature review;Drug Metabolism Reviews;2024-03-20

4. Quercetin inhibits the metabolism of arachidonic acid by inhibiting the activity of CYP3A4, thereby inhibiting the progression of breast cancer;Molecular Medicine;2023-09-14

5. Investigating the relevance of CYP2J2 inhibition for drugs known to cause intermediate to high risk torsades de pointes;European Journal of Pharmaceutical Sciences;2023-08